Regulation of apoptosis-related molecules by synergistic combination of all-trans retinoic acid and zoledronic acid in hormone-refractory prostate cancer cell lines

Molecular Biology Reports

Volumn 38, Issue 1, 2011, Pages 249-259

  Karabulut, Bulent ^a   Karaca, Burcak ^a   Atmaca, Harika ^b   Kisim, Asli ^b   Uzunoglu, Selim ^b   Sezgin, Canfeza ^a   Uslu, Ruchan ^a  

^a EGE UNIVERSITY   (Turkey)

^b CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Apoptosis; ATRA; DU 145; PC 3; Zoledronic acid

Indexed keywords

CASPASE 3; CASPASE 7; CYTOCHROME C; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; HEME OXYGENASE 2; LIVIN; LYMPHOTOXIN BETA RECEPTOR; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN MCL 1; PROTEIN P53; RETINOIC ACID; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SURVIVIN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; ZOLEDRONIC ACID;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DOSE RESPONSE; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MALE; PROSTATE CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASE 3; CASPASE 7; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DIPHOSPHONATES; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GENE EXPRESSION REGULATION, NEOPLASTIC; HORMONES; HUMANS; IMIDAZOLES; MALE; PROSTATIC NEOPLASMS; RECEPTORS, TUMOR NECROSIS FACTOR; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRETINOIN;

INTRACISTERNAL A-PARTICLES;

EID: 78651097528     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0102-6     Document Type: Article

References (39)

1. A Jemal R Siegel E Ward Y Hao J Xu T Murray MJ Thun 2008 Cancer statistics CA Cancer J Clin 55 10 30 10.3322/canjclin.55.1.10
2. MB Garnick 1997 Hormonal therapy in the management of prostate cancer: from Higgins to the present Urology 49 5 15 1:STN:280:DyaK2s3js12qtg%3D%3D 10.1016/S0090-4295(97)00163-5 9123737 (Pubitemid 27133505)
3. PC Albertsen DG Fryback BE Storere 1995 Long term survival among men with conservatively treated localized prostate cancer J Am Med Assoc 274 626 631 1:STN:280:DyaK2MzmsVWntQ%3D%3D 10.1001/jama.274.8.626
4. A Ashkenazi P Holland Eckhardt 2008 Ligand based ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL) J Clin Oncol 26 3621 3630 1:CAS:528:DC%2BD1cXpvVWmtbw%3D 10.1200/JCO.2007.15.7198 18640940
5. H Devlin M Mudryj 2009 Progression of prostate cancer: multiple pathways to androgen independence Cancer Lett 274 177 186 1:CAS:528: DC%2BD1MXns12kuw%3D%3D 10.1016/j.canlet.2008.06.007 18657355
6. JM Kurie WK Hong 1999 Retinoids as antitumor agents: a new age of biological therapy Cancer J Sci Am 5 150 151 1:STN:280:DyaK1M3psFantA%3D%3D 10367170
7. R Lotan 1996 Retinoids in cancer chemoprevention FASEB J 10 1031 1039 1:CAS:528:DyaK28Xks1Wntr0%3D 8801164
8. Y Lotan XC Xu M Shalev R Lotan R Williams TM Wheeler TC Thompson D Kadmon 2000 Differential expression of nuclear retinoid receptors in normal and malignant prostates J Clin Oncol 18 116 121 1:CAS:528:DC%2BD3cXmtFSrug%3D%3D 10623701
9. MA Smith DR Parkinson BD Cheson MA Friedman 1992 Retinoids in cancer therapy J Clin Oncol 10 839 864 1:CAS:528:DyaK38XktF2ksL4%3D 1569455
10. XK Zhang 2002 Vitamin A and apoptosis in prostate cancer Endocr Relat Cancer 9 87 102 1:CAS:528:DC%2BD38XntVeqs78%3D 10.1677/erc.0.0090087 12121833 (Pubitemid 34832162)
11. K Koshiuka E Elstner E Williamson JW Said Y Tada HP Koeffler 2000 Novel therapeutic approach: organic arsenical melarsoprol alone or with all-trans-retinoic acid markedly inhibit growth of human breast and prostate cancer cells in vitro and in vivo Br J Cancer 82 452 458 1:CAS:528: DC%2BD3cXpt12hsQ%3D%3D 10.1054/bjoc.1999.0942 10646904
12. Y Kucukzeybek MK Gul E Cengiz C Erten B Karaca G Gorumlu H Atmaca S Uzunoglu B Karabulut UA Sanli R Uslu 2008 Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145 J Exp Clin Cancer Res 12 27 37
13. RGG Russell MJ Rogers 1999 Bisphosphonates: From the laboratory to the clinic and back again Bone 25 97 106 1:CAS:528:DyaK1MXkvV2ru70%3D 10.1016/S8756-3282(99)00116-7 10423031 (Pubitemid 29322070)
14. JR Green 2003 Antitumor effects of bisphosphonates Cancer 97 840 847 10.1002/cncr.11128 12548584
15. Cengiz E, Karaca B, Kucukzeybek Y, Gorumlu G, Gul MK, Erten C, Atmaca H, Uzunoglu S, Karabulut B, Sanli UA, Uslu R (2010) Overcoming drug resistance in hormone- and drug-refractory prostate cancer cell line, PC-3 by docetaxel and gossypol combination. Mol Biol Rep 37(3):1269-1277. Epub 2009 Mar 14
16. Zaidman BZ, Wasser SP, Nevo E, Mahajna J (2008) Coprinus comatus and Ganoderma lucidum interfere with androgen receptor function in LNCaP prostate cancer cells. Mol Biol Rep 35(2):107-117. Epub 2007 Mar 13
17. TC Chou P Talalay 1984 Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs on enzyme inhibitors Adv Enzyme Regul 22 27 55 1:CAS:528:DyaL2cXktlaksLk%3D 10.1016/0065-2571(84)90007-4 6382953
18. H Hsu HB Shu MG Pan DV Goeddel 1996 TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways Cell 84 299 306 1:CAS:528:DyaK28Xnt1egtA%3D%3D 10.1016/S0092-8674(00)80984-8 8565075 (Pubitemid 26042835)
19. M Muzio AM Chinnaiyan FC Kischkel K O'Rourke A Shevchenko J Ni C Scaffidi JD Bretz M Zhang R Gentz M Mann PH Krammer ME Peter VM Dixit 1996 FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex Cell 85 817 827 1:CAS:528:DyaK28XjslSkurY%3D 10.1016/S0092-8674(00)81266-0 8681377 (Pubitemid 26193033)
20. DP Chopra RE Menard J Januszewski RR Mattingly 2004 TNF-α mediated apoptosis in normal human prostate epithelial cells and tumor cell lines Cancer Lett 203 145 154 1:CAS:528:DC%2BD2cXjsV2ksA%3D%3D 10.1016/j.canlet.2003.09.016 14732222 (Pubitemid 38058682)
21. MP Boldin TM Goncharov Y Goltsev D Wallach 1996 Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death Cell 85 803 815 1:CAS:528:DyaK28XjslSkurk%3D 10.1016/S0092-8674(00) 81265-9 8681376
22. SK Manna BB Aggarwal 2000 All-trans-retinoic acid upregulates TNF receptors and potentiates TNF-induced activation of nuclear factors-κB, activated protein-1 and apoptosis in human lung cancer cells Oncogene 19 2110 2119 1:CAS:528:DC%2BD3cXjsVymtb0%3D 10.1038/sj.onc.1203547 10815802
23. KR McEleny RWG Watson RNT Coffey AJ O'Neill JM Fitzpatrick 2002 Inhibitors of apoptosis proteins in prostate cancer cell lines Prostate 51 133 140 1:CAS:528:DC%2BD38Xkt1Sns7g%3D 10.1002/pros.10061 11948968 (Pubitemid 34492620)
24. I Tamm Y Wang E Sausville DA Scudiero N Vigna T Oltersdorf J Reed 1998 IAP Family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs Cancer Res 58 5315 5320 1:CAS:528:DyaK1cXotVSkt7w%3D 9850056
25. A Suzuki Y Tsutomi K Akahane T Araki M Miura 1998 Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP Oncogene 17 931 939 1:CAS:528:DyaK1cXmtVSmtbo%3D 10.1038/sj.onc.1202021 9747872
26. QL Deveraux N Roy HR Stennicke T Van Arsdale Q Zhou SM Srinivasula ES Alnemri GS Salvesen J Reed 1998 IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases EMBO J 17 2215 2223 1:CAS:528:DyaK1cXivFOmsb8%3D 10.1093/emboj/17.8.2215 9545235 (Pubitemid 28171907)
27. ZL Chu TA McKinsey L Liu JJ Gentry MH Malim DW Ballard 1997 Suppression of tumour necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappa B control Proc Natl Acad Sci USA 94 10057 10062 1:CAS:528:DyaK2sXmt1Cquro%3D 10.1073/pnas.94.19.10057 9294162 (Pubitemid 27406993)
28. C Stehlik R de Martin I Kumabashiri JA Schmid BR Binder J Lipp 1998 Nuclear Factor (NF)-kB-regulated X-chromosome linked iap gene expression protects endothelial cells from tumor necrosis factor a-induced apoptosis J Exp Med 188 211 216 1:CAS:528:DyaK1cXksFyjsLw%3D 10.1084/jem.188.1.211 9653098 (Pubitemid 28328620)
29. GA Manji RR Hozak DJ LaCount PD Friesen 1997 Baculovirus inhibitor of apoptosis functions at or upstream of the apoptotic suppressor p35 to prevent programmed cell death J Virol 71 4509 4516 1:CAS:528:DyaK2sXjt1GntLk%3D 9151843
30. C Adida D Berrebi M Peuchmaur M Reyes-Mugica DC Altieri 1998 Anti-apoptosis gene, survivin, and prognosis of neuroblastoma Lancet 351 882 883 1:STN:280:DyaK1c7osVartA%3D%3D 10.1016/S0140-6736(05)70294-4 9525374 (Pubitemid 28121185)
31. M Monzo R Rosell E Felip J Astudillo JJ Sanchez J Maestre, et al. 1999 A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers J Clin Oncol 17 2100 2104 1:CAS:528:DyaK1MXkvVSmtbc%3D 10561264
32. AI Sarela RC Macadam SM Farmery AF Markham PJ Guillou 2000 Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma Gut 46 645 650 1:CAS:528:DC%2BD3cXjsVShu7Y%3D 10.1136/gut.46.5.645 10764707 (Pubitemid 30305781)
33. K Tanaka S Iwamoto G Gon T Nohara M Iwamoto N Tanigawa 2000 Expression of survivin and its relationship to loss of apoptosis in breast carcinomas Clin Cancer Res 6 127 134 1:CAS:528:DC%2BD3cXhtVCjsr4%3D 10656440
34. J Kato Y Kuwabara M Mitani N Shinoda A Sato T Toyama, et al. 2001 Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy Int J Cancer 95 92 95 1:CAS:528:DC%2BD3MXitV2ks7w%3D 10.1002/1097-0215(20010320)95:2<92::AID-IJC1016>3.0.CO;2-9 11241318 (Pubitemid 32187079)
35. KJ Aichberger M Mayerhofer KV Gleixner MT Krauth A Gruze WF Pickl, et al. 2007 Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412 Blood 109 3031 3041 1:CAS:528:DC%2BD2sXjvVyntrw%3D 17110460
36. MA gli-Esposti T vis-Smith WS Din PJ Smolak RG Goodwin CA Smith 1997 Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells J Immunol 158 1756 1762
37. M Lukashev D LePage C Wilson V Bailly E Garber A Lukashin, et al. 2006 Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy Cancer Res 66 9617 9624 1:CAS:528:DC%2BD28XhtVams7%2FF 10.1158/0008-5472.CAN-06-0217 17018619 (Pubitemid 44623661)
38. H Winter NK van den Engel CH Poehlein RA Hatz BA Fox HM Hu 2007 Tumor-specific T cells signal tumor destruction via the lymphotoxin beta receptor J Transl Med 5 14 26 10.1186/1479-5876-5-14 17355640 (Pubitemid 46505801)
39. M Zhao S Begum PK Ha W Westra J Califano 2008 Downregulation of rad17 in head and neck cancer Head&Neck 30 35 42 (Pubitemid 351158319)